Moreover, NLRP3 inflammasome activation correlates with the severity of disease in COVID-19 patients (Rodrigues et al., 2021) and plays a central role in this excessive inflammatory response (Ratajczak and Kucia, 2020; Shah, 2020; Pan et al., 2021). The gene discussed is NLRP3; the disease is COVID-19.